Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial
Journal name: AYU (Journal of Research in Ayurveda)
Original article title: Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial
AYU is an internationally recognized quarterly journal dedicated to advancing research in Ayurveda. The journal covers a wide range of topics, including clinical and pharmacological research in Ayurveda's eight branches, herbal remedies, phytochemistry, and ethnomedicine.
Original source:
This page is merely a summary which is automatically generated hence you should visit the source to read the original article which includes the author, publication date, notes and references.
Chetan Savaliya
Shridhar Pandya
Kamalesh Thumar
Dheeraj Nagore
AYU (Journal of Research in Ayurveda):
(An International Quarterly Journal of Research in Ayurveda)
Full text available for: Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial
Year: 2023 | Doi: 10.4103/ayu.ayu_92_22
Copyright (license): CC BY-NC-SA 4.0
Download the PDF file of the original publication
Summary of article contents:
Background: The constructive role of Ayurveda in managing COVID-19 has been widely discussed, with identified herbs showing immunomodulatory and anti-viral potential. However, clinical trials examining their safety and efficacy are limited.
Other Science Concepts:
Discover the significance of concepts within the article: �Safety and efficacy of COROPROTECT kit as an add-on therapy in the management of mild-to-moderate COVID-19: A randomized, placebo-controlled trial�. Further sources in the context of Science might help you critically compare this page with similair documents:
Ayurvedic principle, Significant reduction, Ayurvedic formulation, Placebo controlled trial, C-Reactive Protein, Immunomodulatory effect, Health care burden, Randomized double-blind, Clinical recovery, Interleukin-6, COVID-19 management, Anti-viral potential, Lactate dehydrogenase, Symptomatic recovery, Reverse transcriptase-polymerase chain reaction, Standard care, Patients diagnosed, Adverse event.